News
All the latest news from Quadratech Diagnostics. If you would like to receive updates via our newsletter then please sign up here.
MEET US AT THE UK NEQAS CLINICAL AND LABORATORY HAEMOSTASIS MEETING 2026
MEET US We are delighted to announce we will be a proud sponsor and exhibitor at the upcoming UK NEQAS Clinical and Laboratory Haemostasis Annual Scientific Meeting in Sheffield. We very much look forward to meeting those in attendance and will be happy to discuss our offering of diagnostic reagents and kits for the investigation […]
Oropouche Virus: Diagnostic Gaps and Research Roadmap
Oropouche Virus (OROV): Diagnostic Gaps and Research Roadmap Oropouche virus (OROV) has transitioned from a localised threat in the Amazonia to a broader public health priority. Since late 2023, the World Health Organization (WHO) and the UK Health Security Agency (UK HSA) have recorded its expansion into the Caribbean and South America, alongside travel-associated cases […]
Key Takeaways and Highlights from BSHT ASM 2026
The BSHT Annual Scientific Meeting (ASM) took place in Cardiff this year, bringing together over 170 attendees, the largest delegation for years. Hosted by the British Society for Haemostasis and Thrombosis (BSHT), the meeting continues to serve as a premier platform for advancing research, clinical practice, and education in blood-clotting disorders in the UK. The […]
Haemostasis News Q1 2026
Our round-up of the latest developments from across the haemostasis industry for Q1 2026. REGULATORY FDA approved a new 2-gram presentation of Octapharma’s Fibryga (lyophilised human fibrinogen) for fibrinogen replacement in patients with acquired fibrinogen deficiency (AFD), building on its FDA approval in 2024 for a 1-gram presentation with nextaro reconstitution device (7 Jan) FDA granted […]
2025 Christmas and New Year Shipping Details
As Christmas and the New Year are approaching rapidly we would would like to inform our customer of our amended operating hours. This year we will be closing our office for the holidays on 12:00 noon Wednesday 24/12/25 until Monday 05/01/26. For International shipments: The last normal shipping day is Monday 15/12/25 with normal service […]
Haemostasis Q4 2025 Journal Club
Keep informed about evolving science and clinical practice with our compilation of the latest studies, guidelines, and perspectives in haemostasis. GUIDELINES Jennings I, Baker P, Bowyer A, et al. Reporting haemostasis assays in IU/dL-A recommendation for harmonisation from the British Society for Haematology Haemostasis and Thrombosis Task Force, UK NEQAS for Blood Coagulation and the […]
Haemostasis Q4 2025 News
Our round-up of the latest developments from across the haemostasis industry for Q4 2025. REGULATORY TAHO Pharma submitted the New Drug Application to the FDA for TAH3311 (apixaban oral dissolving film), developed on its proprietary Transepithelial Delivery System (1 Oct) ADLM (Association for Diagnostics & Laboratory Medicine) released new guidance on coagulation testing in patients […]
Harnessing bacteria’s potential: Cholera Toxin Products
Harnessing bacteria’s potential: Cholera Toxin Products Cholera toxin is produced by Vibrio cholerae, a gram-negative bacterium, and is the main virulence factor in the development of cholera, a waterborne acute diarrheal disease. As a classic AB Type toxin, cholera toxin consists of a single A subunit surrounded by five identical B subunits, arranged as pentamer […]
UK NEQAS for Laboratory and Clinical Haemostasis 2025 Reflections
UK NEQAS for Laboratory and Clinical Haemostasis 2025: Key Takeaways and Reflections by Quadratech Diagnostics Team In June, we were delighted to sponsor UK NEQAS Blood Coagulation Annual Scientific Meeting in Sheffield. We truly valued the opportunity to meet with our existing customers and to welcome new participants interested in our diagnostic solutions. The two-day […]
Haemostasis Q3 2025 Journal Club
Keep informed about evolving science and clinical practice with our compilation of the latest studies, guidelines, and perspectives in haemostasis. GUIDELINES Barrett WJ, Kaucher KA, Orpet RE, et al. Tranexamic acid in trauma: A joint position statement and resource document of NAEMSP, ACEP, and ACS-COT. J Trauma Acute Care Surg. 2025;99(3):357-363. doi:10.1097/TA.0000000000004727 Lier H, Goossen K, […]
Haemostasis Q3 2025 News
Our round-up of the latest developments from across the haemostasis industry for Q3 2025. REGULATORY Novo Nordisk’s Alhemo (concizumab-mtci, a tissue factor pathway inhibitor antagonist) injection received positive opinion by the EMA CHMP, recommending label expansion to include the treatment of severe haemophilia A and moderate or severe haemophilia B without inhibitors (25 Jul) Kedrion […]
Haemostasis Q2 2025 News
Our round-up of the latest developments from across the haemostasis industry for Q2 2025, including the latest data presentations at ISTH 2025. REGULATORY FDA approved Bayer’s Jivi (a recombinant extended half-life factor VIII concentrate) for use in paediatric patients 7 years of age and older with haemophilia A based on Alfa-PROTECT and PROTECT Kids trial […]
